HIKMA Pharmaceuticals
HIK · London Stock Exchange (primary) / ASE (secondary) · Pharmaceuticals · US listing: HKMPY
About the company
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman in 1978 that has grown into one of the world's leading generic drug manufacturers, with primary listing on the London Stock Exchange. The company manufactures injectables, branded generics, and proprietary drugs sold across the Middle East, North Africa, the US, and Europe. While its primary market is London (HIK LN), it maintains historical and operational roots in Jordan.
| Exchange | London Stock Exchange (primary) / ASE (secondary) |
| Ticker | HIK |
| Sector | Pharmaceuticals |
| US listing | HKMPY |
| Indicative market cap USD | $4.20B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
Trades in the US as HKMPY — available through most US brokerage accounts.
On its home market (London Stock Exchange (primary) / ASE (secondary)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Amman Stock Exchange — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in Jordan
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.